Anemia and Associated Factors Among Adults with Human Immune Deficiency Virus on Antiretroviral Therapy in Public Health Facilities of Kembata Tembaro Zone, Southern Ethiopia: A Cross-Sectional Study.

ART BMI HIV Kembata Tembaro Zidovudine adults anemia

Journal

HIV/AIDS (Auckland, N.Z.)
ISSN: 1179-1373
Titre abrégé: HIV AIDS (Auckl)
Pays: New Zealand
ID NLM: 101515943

Informations de publication

Date de publication:
2020
Historique:
received: 21 04 2020
accepted: 03 07 2020
entrez: 5 9 2020
pubmed: 5 9 2020
medline: 5 9 2020
Statut: epublish

Résumé

Anemia is an independent prognostic marker of HIV/AIDS disease progression. It causes impaired physical functioning, psychological distress, poor quality-of-life, and reduces life expectancy in HIV patients. However, there is limited information in Ethiopia. Therefore, the aim of this study was to assess the magnitude of anemia and associated factors among adult HIV patients on antiretroviral therapy in public health facilities of Kembata Tembaro Zone, southern Ethiopia. We conducted a facility-based cross-sectional study. A total of 401 HIV patients attending antiretroviral therapy nested in five health facilities were included in the analysis. Simple random sampling was employed using medical record number to select study units. Data were collected using pretested and structured questionnaire, anthropometric measurements were taken, and a drop of capillary blood was collected to determine hemoglobin level by HemoCue 301 analyzer. Clinical related data were collected from patient medical records by using a structured checklist. The collected data were coded and entered into EpiData version 3.1 and exported to SPSS version 20 for analysis. Logistic regression analysis was carried out to identify factors associated with anemia and statistical tests were declared significant at a The magnitude of anemia among adults HIV patients attending ART was 26.2%, 95% CI=21.7-30.4. Being female (AOR=2.06, 95% CI=1.02-4.16), body mass index <18.5 Kg/m Anemia was found to be a moderate public health problem among ART attendants in the current study area. Thus, early detection and intervention targeting Zidovudine users, females, patients having body mass index <18.5 Kg/m

Sections du résumé

BACKGROUND BACKGROUND
Anemia is an independent prognostic marker of HIV/AIDS disease progression. It causes impaired physical functioning, psychological distress, poor quality-of-life, and reduces life expectancy in HIV patients. However, there is limited information in Ethiopia. Therefore, the aim of this study was to assess the magnitude of anemia and associated factors among adult HIV patients on antiretroviral therapy in public health facilities of Kembata Tembaro Zone, southern Ethiopia.
METHODS METHODS
We conducted a facility-based cross-sectional study. A total of 401 HIV patients attending antiretroviral therapy nested in five health facilities were included in the analysis. Simple random sampling was employed using medical record number to select study units. Data were collected using pretested and structured questionnaire, anthropometric measurements were taken, and a drop of capillary blood was collected to determine hemoglobin level by HemoCue 301 analyzer. Clinical related data were collected from patient medical records by using a structured checklist. The collected data were coded and entered into EpiData version 3.1 and exported to SPSS version 20 for analysis. Logistic regression analysis was carried out to identify factors associated with anemia and statistical tests were declared significant at a
RESULTS RESULTS
The magnitude of anemia among adults HIV patients attending ART was 26.2%, 95% CI=21.7-30.4. Being female (AOR=2.06, 95% CI=1.02-4.16), body mass index <18.5 Kg/m
CONCLUSION CONCLUSIONS
Anemia was found to be a moderate public health problem among ART attendants in the current study area. Thus, early detection and intervention targeting Zidovudine users, females, patients having body mass index <18.5 Kg/m

Identifiants

pubmed: 32884360
doi: 10.2147/HIV.S259259
pii: 259259
pmc: PMC7431452
doi:

Types de publication

Journal Article

Langues

eng

Pagination

341-349

Informations de copyright

© 2020 Mengistu et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

PLoS One. 2019 Feb 13;14(2):e0211708
pubmed: 30759131
Popul Health Metr. 2017 Mar 29;15(1):12
pubmed: 28356159
BMC Hematol. 2018 Nov 12;18:32
pubmed: 30459953
BMC Hematol. 2013 Aug 09;13(1):8
pubmed: 24238076
PLoS One. 2013 Aug 16;8(8):e72202
pubmed: 23977253
J Res Med Sci. 2012 Feb;17(2):138-42
pubmed: 23264786
Hematol Oncol Clin North Am. 2016 Apr;30(2):247-308
pubmed: 27040955
Adv Hematol. 2019 Mar 3;2019:9614205
pubmed: 30941180
HIV AIDS (Auckl). 2017 Feb 14;9:25-30
pubmed: 28243151
Pan Afr Med J. 2016 Feb 04;23:26
pubmed: 27200131
BMC Res Notes. 2019 Mar 25;12(1):168
pubmed: 30909968
Tanzan J Health Res. 2009 Jan;11(1):1-4
pubmed: 19445097
Food Nutr Bull. 2008 Sep;29(3):186-94
pubmed: 18947031
J Trop Med. 2013;2013:162950
pubmed: 24069036
BMC Hematol. 2018 Mar 15;18:7
pubmed: 29568529

Auteurs

Abrham Mengistu (A)

Department of Public Health, College of Medicine and Health Science, Wachemo University, Hosaena, Ethiopia.

Gudina Egata (G)

School of Public Health, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Behailu Hawulte (B)

School of Public Health, College of Health and Medical Science, Haramaya University, Harar, Ethiopia.

Melese Markos (M)

Department of Public Health, College of Health Science, Dire Dawa University, Dire Dawa, Ethiopia.

Tsegaye Lolaso (T)

School of Public Health, College of Health Science and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia.

Classifications MeSH